SCHEMBL23940459

SCHEMBL23940459

CCC1CCc2cc(P)ccc2O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
CA2 P00918 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
ALPG P10696 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
HTR1A P08908 2/20 0.33
ADRA2A P08913 2/20 0.33
ADRA2B P18089 2/20 0.33
ADRA2C P18825 2/20 0.33
SIGMAR1 Q99720 1/20 0.33
MLNR O43193 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8499319 0.81 HTR1A (0.51) CYP4F2CYP4A11ESR1ESR2HTR1A
SCHEMBL16650295 0.81 CA2 (0.38) CYP4F2CYP4A11ESR1ESR2CA2
SCHEMBL27760165 0.81 HTR1A (0.51) CYP4F2CYP4A11ESR1ESR2HTR1A
SCHEMBL13979873 0.81 HTR1A (0.51) CYP4F2CYP4A11ESR1ESR2HTR1A
SCHEMBL23940440 0.78 TDP1 (0.38) CYP4F2CYP4A11ESR1ESR2HTR1A
SCHEMBL14271049 0.76 CA2 (0.55) CA2CYP1A2CYP2D6ALPGCYP2C19
SCHEMBL6051185 0.76 CA2 (0.55) CA2CYP1A2CYP2D6ALPGCYP2C19
SCHEMBL19931577 0.76 ITGB3 (0.41) CYP4F2CYP4A11CA2SMN1; SMN2ITGB3
SCHEMBL22663014 0.76 TDP1 (0.55) CYP4F2CYP4A11ITGB3ITGA2BDRD2
SCHEMBL16650443 0.75 PNMT (0.46) SMN1; SMN2ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299364-B1 NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF ZHEJIANG AUSUN PHARMACEUTICAL CO LTD (CN) 2021-10-20 EP disclosed